Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

BACKGROUND: We studied the comparative effectiveness of biosimilar filgrastim vs original filgrastim in patients with chemotherapy-induced neutropenia. PATIENTS AND METHODS: This multicenter, observational study was conducted at 14 centers. The study included 337 patients experiencing neutropenia un...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevinç, Alper, Özkan, Metin, Özet, Ahmet, Dane, Faysal, Öksüzoğlu, Berna, Işıkdoğan, Abdurrahman, Özdemir, Feyyaz, Uncu, Doğan, Gümüş, Mahmut, Evrensel, Türkkan, Yaren, Arzu, Kara, Oğuz, Tekin, Salim Başol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783019/
https://www.ncbi.nlm.nih.gov/pubmed/29403286
http://dx.doi.org/10.2147/OTT.S106342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783019/
https://www.ncbi.nlm.nih.gov/pubmed/29403286
http://dx.doi.org/10.2147/OTT.S106342

Ejemplares similares